Consumer Retailing Healthcare Sector

Rapid Dose Therapeutics

Market Cap: CA$27.0m

A life sciences company, provides drug delivery technologies designed to enhance patient outcomes in Canada.

OptiBiotix Health

Market Cap: UK£14.4m

A life sciences company, engages in the discovery and development of microbiome modulators in the United Kingdom, the United States, China, and internationally.

Cognition Therapeutics

Market Cap: US$19.5m

A clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.

Greenway Greenhouse Cannabis

Market Cap: CA$26.4m

Engages in the cultivation, processing, and sale of dried cannabis.

Polarean Imaging

Market Cap: UK£14.2m

Operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States.

Retractable Technologies

Market Cap: US$19.2m

Designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally.

Elite Health Systems

Market Cap: US$19.1m

Through its subsidiaries, develops a business to provide Medicare Advantage plans and related services in California and Nevada.

Elevation Oncology

Market Cap: US$19.0m

An oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs.

BioVie

Market Cap: US$19.0m

A clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease.

Third Age Health Services

Market Cap: NZ$31.9m

Provides health care services for residential aged care facilities, private hospitals, and secure dementia in New Zealand.

Cyclacel Pharmaceuticals

Market Cap: US$18.9m

A clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States.

Ananda Pharma

Market Cap: UK£14.0m

Invests in the medicinal and therapeutic cannabis market in the United Kingdom and internationally.

Lexaria Bioscience

Market Cap: US$18.9m

Operates as a biotechnology company.

Jupiter Neurosciences

Market Cap: US$18.8m

A clinical stage research and development pharmaceutical company, develops resveratrol platform products for the treatment of neuroinflammation.

X4 Pharmaceuticals

Market Cap: US$18.7m

A biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system.

DiagnosTear Technologies

Market Cap: CA$25.3m

An ophthalmic company, engages in developing and commercializing disruptive diagnostic solutions for eye diseases.

PetVivo Holdings

Market Cap: US$18.4m

A biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals.

Nyrada

Market Cap: AU$28.5m

A pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases.

Clever Culture Systems

Market Cap: AU$28.3m

Engages in the research, development, and commercialization of technology solutions for medical industry in Australia, the United States, Sweden, the United Kingdom, and Germany.

MultiCorp International

Market Cap: US$18.2m

Does not have significant operations.

DIAGNOS

Market Cap: CA$25.0m

Provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally.

BCAL Diagnostics

Market Cap: AU$27.8m

A screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer.

Stella Diagnostics

Market Cap: US$18.0m

A research diagnostics company, engages in developing molecular diagnostics tools and new drug targets for esophageal diseases.

ImmuPharma

Market Cap: UK£13.3m

A biopharmaceutical company, discovers and develops peptide-based therapeutics in the United Kingdom.

Adagio Medical Holdings

Market Cap: US$17.7m

A developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias.

Gelteq

Market Cap: US$17.5m

Focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals in Asia-Pacific Region.

Bullfrog AI Holdings

Market Cap: US$17.4m

Through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States.

Treatment.com AI

Market Cap: CA$23.8m

Treatment.Com International Inc. provides personalized health care information services in Canada.

SAB Biotherapeutics

Market Cap: US$17.3m

A clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders.

Devonian Health Group

Market Cap: CA$23.7m

Engages in the development of botanical drugs.

VSee Health

Market Cap: US$17.3m

Provides telehealth care solutions.

NEXGEL

Market Cap: US$17.2m

Manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States.

Aurora Spine

Market Cap: CA$23.6m

Through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada.

C21 Investments

Market Cap: CA$23.6m

An integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States.

Nova Leap Health

Market Cap: CA$23.6m

Provides home and home health care services in the United States and Canada.

DURECT

Market Cap: US$16.9m

A biopharmaceutical company, develops medicines based on its epigenetic regulator program.